These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14576898)

  • 21. Antiretroviral treatment for injecting drug users in developing and transitional countries 1 year before the end of the "Treating 3 million by 2005. Making it happen. The WHO strategy" ("3 by 5").
    Aceijas C; Oppenheimer E; Stimson GV; Ashcroft RE; Matic S; Hickman M
    Addiction; 2006 Sep; 101(9):1246-53. PubMed ID: 16911723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inequalities in health: access to treatment for HIV/AIDS.
    Giuliano M; Vella S
    Ann Ist Super Sanita; 2007; 43(4):313-6. PubMed ID: 18209264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WHO to reaffirm health for all.
    Piel A
    Lancet; 2003 May; 361(9369):1653. PubMed ID: 12747907
    [No Abstract]   [Full Text] [Related]  

  • 24. Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting.
    Tam LW; Hogg RS; Yip B; Montaner JS; Harrigan PR; Brumme CJ
    HIV Med; 2007 Jul; 8(5):267-70. PubMed ID: 17561871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WHO and UNAIDS unveil plans for 3 by 5 AIDS programme.
    Rassool GH
    J Adv Nurs; 2004 Jun; 46(5):567-9. PubMed ID: 15171242
    [No Abstract]   [Full Text] [Related]  

  • 26. The next Director-General of WHO.
    Horton R
    Lancet; 2006 Oct; 368(9543):1213-4. PubMed ID: 17027707
    [No Abstract]   [Full Text] [Related]  

  • 27. Social aspects of antiretroviral therapy scale-up: introduction and overview.
    Hirsch JS; Parker RG; Aggleton P
    AIDS; 2007 Oct; 21 Suppl 5():S1-4. PubMed ID: 18090262
    [No Abstract]   [Full Text] [Related]  

  • 28. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WHO launches new leadership, new priorities.
    The Lancet
    Lancet; 2017 Oct; 390(10104):1716. PubMed ID: 29047430
    [No Abstract]   [Full Text] [Related]  

  • 31. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B; Jack C; Ramjee G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strengthening WHO's position should be a priority for the new Director-General.
    Bluestone K
    Lancet; 2003 Jan; 361(9351):2. PubMed ID: 12521031
    [No Abstract]   [Full Text] [Related]  

  • 33. Usefulness of an observational database to assess antiretroviral treatment trends in India.
    Cecelia AJ; Christybai P; Anand S; Jayakumar K; Gurunathan T; Vidya P; Solomon S; Kumarasamy N
    Natl Med J India; 2006; 19(1):14-7. PubMed ID: 16570679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Change of leadership for WHO in 2003.
    Bull World Health Organ; 2002; 80(10):844. PubMed ID: 12471412
    [No Abstract]   [Full Text] [Related]  

  • 37. Is the time for an AIDS-free new generation different in resource-limited and industrialized countries?
    Russo G; Lichtner M; Traditi F; Vullo V
    AIDS; 2009 Jan; 23(3):293-6. PubMed ID: 19114853
    [No Abstract]   [Full Text] [Related]  

  • 38. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
    Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
    AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of intrauterine devices and systems by HIV-infected women.
    Castaño PM
    Contraception; 2007 Jun; 75(6 Suppl):S51-4. PubMed ID: 17531617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New trends in HIV disease worldwide.
    Laurence J
    AIDS Read; 2003 Dec; 13(12):569-70. PubMed ID: 14959689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.